Literature DB >> 26584837

Transgenic expression of human CD46: does it reduce the primate T-cell response to pig endothelial cells?

Mohamed B Ezzelarab1, David Ayares2, David K C Cooper3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26584837     DOI： 10.1111/xen.12209

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN： 0908-665X            Impact factor:   3.907


× No keyword cloud information.
  11 in total

Review 1.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

2.  B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Authors:  Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase
Journal:  Transpl Immunol       Date:  2018-08-06       Impact factor: 1.708

3.  Xenotransplanted Pig Sertoli Cells Inhibit Both the Alternative and Classical Pathways of Complement-Mediated Cell Lysis While Pig Islets Are Killed.

Authors:  Kandis Wright; Rachel Dziuk; Payal Mital; Gurvinder Kaur; Jannette M Dufour
Journal:  Cell Transplant       Date:  2016-11       Impact factor: 4.064

Review 4.  Progress in Clinical Encapsulated Islet Xenotransplantation.

Authors:  David K C Cooper; Shinichi Matsumoto; Adrian Abalovich; Takeshi Itoh; Nizar I Mourad; Pierre R Gianello; Eckhard Wolf; Emanuele Cozzi
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

Review 5.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

6.  Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs.

Authors:  Whayoung Lee; Hidetaka Hara; Mohamed B Ezzelarab; Hayato Iwase; Rita Bottino; Cassandra Long; Jagdeece Ramsoondar; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2016-03-14       Impact factor: 3.907

Review 7.  Xenotransplantation: A New Era.

Authors:  Amber N Carrier; Anjali Verma; Muhammad Mohiuddin; Manuel Pascual; Yannick D Muller; Alban Longchamp; Chandra Bhati; Leo H Buhler; Daniel G Maluf; Raphael P H Meier
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 8.  Low anti-pig antibody levels are key to the success of solid organ xenotransplantation: But is this sufficient?

Authors:  David K C Cooper; Mohamed B Ezzelarab; Hidetaka Hara
Journal:  Xenotransplantation       Date:  2017-10-25       Impact factor: 3.907

Review 9.  Skin xenotransplantation: Historical review and clinical potential.

Authors:  Takayuki Yamamoto; Hayato Iwase; Timothy W King; Hidetaka Hara; David K C Cooper
Journal:  Burns       Date:  2018-03-27       Impact factor: 2.744

Review 10.  Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation.

Authors:  David K C Cooper; Mohamed Ezzelarab; Hayato Iwase; Hidetaka Hara
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.